Clinical Trial Site

Lexington, Kentucky 40536

2 studies enrolling now · 5 studies all time

What they study most

ANCA-Associated Vasculitis, Cerebral Amyloid Angiopathy, Dravet Syndrome, Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Lennox Gastaut Syndrome, Tuberous Sclerosis Complex

Studies at this site

• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed